In addition, LYN overexpression has been reported in several cancers, such as chronic myelogenous leukemia [15], colorectal cancer [16], breast cancer [17], prostate cancer [18], oral cancer [19], renal cancer [20] and gastric cancer [21]. Here, LYN is linked to breast cancer.